These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 660561

  • 1. Relationship between acetylcholinesterase inhibition and the development of a myopathy.
    Wecker L, Kiauta T, Dettbarn WD.
    J Pharmacol Exp Ther; 1978 Jul; 206(1):97-104. PubMed ID: 660561
    [No Abstract] [Full Text] [Related]

  • 2. An electrophysiological analysis of the effects of paraoxon at the neuromuscular junction.
    Laskowski MB, Dettbarn WD.
    J Pharmacol Exp Ther; 1979 Aug; 210(2):269-74. PubMed ID: 458633
    [No Abstract] [Full Text] [Related]

  • 3. Presynaptic effects of neuromuscular cholinesterase inhibition.
    Laskowski MB, Dettbarn WD.
    J Pharmacol Exp Ther; 1975 Aug; 194(2):351-61. PubMed ID: 1151764
    [Abstract] [Full Text] [Related]

  • 4. Neuromuscular dysfunction induced by acetylcholinesterase inhibition.
    Wecker L, Laskowski B, Dettbarn WD.
    Fed Proc; 1978 Dec; 37(14):2818-22. PubMed ID: 214351
    [Abstract] [Full Text] [Related]

  • 5. [Acetylcholinesterase at the motor end plate of the rat diaphragm after poisoning with Paraoxon and Soman during application of oximes].
    Fischer G.
    Experientia; 1970 Apr 15; 26(4):402-3. PubMed ID: 5439615
    [No Abstract] [Full Text] [Related]

  • 6. Histological and histochemical study of paraoxon myopathy in the rat.
    De Bleecker J, Willems J, De Reuck J, Santens P, Lison D.
    Acta Neurol Belg; 1991 Apr 15; 91(5):255-70. PubMed ID: 1781262
    [Abstract] [Full Text] [Related]

  • 7. Variable involvement of rat skeletal muscles in paraoxon-induced necrotizing myopathy.
    De Bleecker JL, van den Abeele KG, De Reuck JL.
    Res Commun Chem Pathol Pharmacol; 1992 Mar 15; 75(3):309-22. PubMed ID: 1509200
    [Abstract] [Full Text] [Related]

  • 8. [Inhibition of cholinesterases and development of the skeletal muscles and myocardium in the chick embryo].
    Manin D, Zatti P.
    Boll Soc Ital Biol Sper; 1968 Oct 15; 44(19):1583-6. PubMed ID: 5712364
    [No Abstract] [Full Text] [Related]

  • 9. An experimental myopathy secondary to excessive acetylcholine release.
    Fenichel GM, Dettbarn WD, Newman TM.
    Neurology; 1974 Jan 15; 24(1):41-5. PubMed ID: 4359000
    [No Abstract] [Full Text] [Related]

  • 10. Nitric oxide is involved in acetylcholinesterase inhibitor-induced myopathy in rats.
    Jeyarasasingam G, Yeluashvili M, Quik M.
    J Pharmacol Exp Ther; 2000 Oct 15; 295(1):314-20. PubMed ID: 10991996
    [Abstract] [Full Text] [Related]

  • 11. [Inhibition of cholinesterase in the myoneural synapses by decamethonium and ditilin].
    Danilov AF.
    Farmakol Toksikol; 1967 Oct 15; 30(6):664-9. PubMed ID: 5598433
    [No Abstract] [Full Text] [Related]

  • 12. Pyroantimonate deposition patterns observed in the motor endplate myopathy following esterase inactivation.
    Kawabuchi M, Osame M, Kanaseki T, Igata A.
    Fukuoka Igaku Zasshi; 1986 Nov 15; 77(11):631-9. PubMed ID: 3817721
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of so-called "depolarizing" and "repolarizing" substances on neuromuscular excitability].
    Quevauviller A, Levy JC.
    Anesth Analg (Paris); 1967 Nov 15; 24(2):247-68. PubMed ID: 4383825
    [No Abstract] [Full Text] [Related]

  • 14. Effect of cholinesterase inhibitors on the susceptibility to pentetrazole of the mouse.
    György L, Döda M.
    Acta Physiol Acad Sci Hung; 1974 Nov 15; 45(3-4):243-51. PubMed ID: 4471270
    [No Abstract] [Full Text] [Related]

  • 15. Modification of the level of acetylcholinesterase activity by two oximes in certain brain regions and peripheral tissues of paraoxon treated rats.
    Matin MA, Siddiqui RA.
    Pharmacol Res Commun; 1982 Mar 15; 14(3):241-6. PubMed ID: 7100228
    [No Abstract] [Full Text] [Related]

  • 16. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
    Hasan MY, Nurulain SM, Arafat K, Naseer OP, Petroianu GA.
    J Appl Toxicol; 2004 Mar 15; 24(4):257-60. PubMed ID: 15300712
    [Abstract] [Full Text] [Related]

  • 17. Reactivatability of soman-inhibited end plate cholinesterase and neuromuscular transmission.
    Murtha EF, Fleisher JH, Torre MA, Innerebner TA.
    Toxicol Appl Pharmacol; 1970 Jan 15; 16(1):214-26. PubMed ID: 4313633
    [No Abstract] [Full Text] [Related]

  • 18. Accumulation of acetylcholinesterase at newly formed nerve--muscle synapases.
    Rubin LL, Schuetze SM, Fischbach GD.
    Dev Biol; 1979 Mar 15; 69(1):46-58. PubMed ID: 446898
    [No Abstract] [Full Text] [Related]

  • 19. Initial ultrastructural abnormalities at the motor end plate produced by a cholinesterase inhibitor.
    Laskowski MB, Olson WH, Dettbarn WD.
    Exp Neurol; 1977 Oct 15; 57(1):13-33. PubMed ID: 891686
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of glucocorticoids on striated muscles (review of the literature)].
    Sergeev PV, Nezhentsev MV.
    Farmakol Toksikol; 1981 Oct 15; 44(6):737-42. PubMed ID: 7030778
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.